Related Experiment Video
Updated: May 13, 2025
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Targeting the TLK1-MK5 Axis Suppresses Prostate Cancer Metastasis
Damilola Olatunde1, Omar Coronel Franco1, Matthias Gaestel2
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA.
Abstract:
Background: The spread of metastatic prostate cancer (PCa) is responsible for the majority of PCa-related deaths, yet the precise mechanisms driving this process remain unclear. We have identified a novel interaction between two distinct promotility factors, tousled-like kinase 1 (TLK1) and MAPK-activated protein kinase 5 (MK5), which triggers a signaling cascade that promotes metastasis. In PCa, the TLK1-MK5 pathway may play a critical role, as androgen deprivation therapy (ADT) has been linked to increased expression of both TLK1 and MK5 in metastatic patients linked with poor survival. Objectives: In this study, we directly examined the effects of disrupting the TLK1>MK5 axis on the motility, invasiveness, and metastatic potential of PCa cells. Methods: To establish this, we used both pharmacologic and systemic approaches with genetically engineered mouse models and the use of IVIS. Results: The results of targeting the TLK1>MK5 axis support the notion that this axis is essential for the spread of metastatic cells and the development of age-related metastases.
Insights
Targeting the TLK1-MK5 pathway inhibits prostate cancer (PCa) metastasis. Disrupting this signaling cascade reduces PCa cell motility and invasiveness, crucial for preventing cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastatic prostate cancer (PCa) causes most PCa deaths, with unclear spread mechanisms.
- A novel TLK1-MK5 interaction promotes metastasis via a signaling cascade.
- Increased TLK1/MK5 expression in metastatic PCa patients correlates with poor survival, especially after androgen deprivation therapy (ADT).
Purpose of the Study:
- To investigate the role of the TLK1-MK5 axis in PCa metastasis.
- To determine the effects of disrupting the TLK1>MK5 axis on PCa cell characteristics.
Main Methods:
- Utilized pharmacologic and systemic approaches.
- Employed genetically engineered mouse models.
- Assessed outcomes using in vivo imaging (IVIS).
Main Results:
- Targeting the TLK1>MK5 axis was essential for metastatic cell spread.
- Disruption of the TLK1>MK5 axis inhibited PCa cell motility and invasiveness.
- This pathway is critical for the development of age-related metastases.
Conclusions:
- The TLK1-MK5 axis is a key driver of prostate cancer metastasis.
- Inhibiting the TLK1-MK5 pathway represents a potential therapeutic strategy for metastatic PCa.
- Further research into this axis could lead to improved treatments for advanced prostate cancer.
More Related Videos
06:32Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
